Quantum Biopharma (QNTM) Cash from Investing Activities (2019 - 2026)

Quantum Biopharma (QNTM) has 7 years of Cash from Investing Activities data on file, last reported at -$2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 114.28% year-over-year to -$2.9 million; the trailing twelve-month figure through Mar 2026 stood at -$2.6 million (down 122.49% YoY), and the FY2025 full-year result was -$2.0 million, down 29.86% from the prior year.
• Cash from Investing Activities slipped to -$2.9 million in Q1 2026, from $350650.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $11.9 million in Q4 2022 to a low of -$2.9 million in Q1 2026.
• A 4-year average of $1.3 million and a median of -$22140.0 in 2024 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 71.81% in 2025, while the deepest fall reached 5998.5% in 2025.
• Tracing QNTM's Cash from Investing Activities over 4 years: stood at $11.9 million in 2022, then plunged by 89.55% to $1.2 million in 2024, then plunged by 71.81% to $350650.0 in 2025, then sank by 925.11% to -$2.9 million in 2026.
• Business Quant data shows QNTM's Cash from Investing Activities at -$2.9 million in Q1 2026, $350650.0 in Q4 2025, and -$1.4 million in Q1 2025.